Combination of Transient Elastography and an Enhanced Liver Fibrosis Test to Assess the Degree of Liver Fibrosis in Patients with Chronic Hepatitis B

被引:12
|
作者
Heo, Ja Yoon [1 ]
Kim, Beom Kyung [1 ,2 ]
Park, Jun Yong [1 ,2 ]
Kim, Do Young [1 ,2 ]
Ahn, Sang Hoon [1 ,2 ]
Kim, Hyon-Suk [3 ]
Park, Young Nyun [4 ]
Han, Kwang-Hyub [1 ,2 ]
Song, Kijun [5 ]
Kim, Seung Up [1 ,2 ]
机构
[1] Yonsei Univ, Coll Med, Dept Internal Med, 50-1 Yonsei Ro, Seoul 03722, South Korea
[2] Yonsei Univ, Coll Med, Inst Gastroenterol, Seoul, South Korea
[3] Yonsei Univ, Coll Med, Dept Lab Med, Seoul, South Korea
[4] Yonsei Univ, Coll Med, Dept Pathol, Seoul, South Korea
[5] Yonsei Univ, Coll Med, Dept Biostat, 50-1 Yonsei Ro, Seoul 03722, South Korea
基金
新加坡国家研究基金会;
关键词
Hepatitis B; chronic; Enhanced liver fibrosis; Liver cirrhosis; Transient elastography; Liver stiffness; HEPATOCELLULAR-CARCINOMA RISK; CHRONIC VIRAL-HEPATITIS; STIFFNESS MEASUREMENT; CLINICAL-OUTCOMES; ELF SCORE; MANAGEMENT; VALIDATION; FIBROTEST; DIAGNOSIS;
D O I
10.5009/gnl17092
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Liver stiffness (LS) was assessed using transient elastography, and the enhanced liver fibrosis (ELF) test was performed to accurately assess fibrotic burden. We validated the LS-ELF algorithm and investigated whether the sequential LS-ELF algorithm performs better than concurrent combination of these analyses in chronic hepatitis B (CHB) patients. Methods: Between 2009 and 2013, 222 CHB patients who underwent liver biopsy (LB), as well as LS measurement and the ELF test, were enrolled. Results: Advanced fibrosis (>= F3) and cirrhosis (F4) were identified in 141 (63.6%) and 118 (53.2%) patients, respectively. Areas under receiver operating characteristic curve for LS predictions of >= F3 (0.887 vs 0.703) and F4 (0.853 vs 0.706) were significantly higher than the ELF test (all p<0.001). Based on the LS-ELF algorithm, 60.4% to 71.6% and 55.7% to 66.3% of patients could have avoided LB to exclude >= F3 and F4, respectively, whereas 68.0% to 78.7% and 63.5% to 66.1% of patients could have avoided LB to confirm >= F3 and F4, respectively. When confirmation and exclusion strategies were applied simultaneously, 69.4% to 72.5% and 60.8% to 65.3% of patients could have avoided LB and been diagnosed as >= F3 and F4, respectively. The proportion of patients who correctly avoided LB for the prediction of >= F3 (69.4% to 72.5% vs 42.3% to 59.0%) and F4 (60.8% to 65.3% vs 23.9% to 49.5%) based on the sequential LS-ELF algorithm was significantly higher than the concurrent combination (all p<0.05). Conclusions: The sequential LS-ELF algorithm conferred a greater probability of avoiding LB in CHB patients to diagnose advanced fibrosis and cirrhosis, and this test performed significantly better than the concurrent combination.
引用
收藏
页码:190 / 200
页数:11
相关论文
共 50 条
  • [21] Cost-effectiveness of enhanced liver fibrosis test to assess liver fibrosis in chronic hepatitis C virus and alcoholic liver disease patients
    Marcelo Soto
    Laura Sampietro-Colom
    Luis Lasalvia
    Aurea Mira
    Wladimiro Jiménez
    Miquel Navasa
    World Journal of Gastroenterology, 2017, 23 (17) : 3163 - 3173
  • [22] Liver fibrosis diagnosis by blood test and elastography in chronic hepatitis C: agreement or combination?
    Cales, P.
    Boursier, J.
    Lebigot, J.
    de Ledinghen, V.
    Aube, C.
    Hubert, I.
    Oberti, F.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (07) : 991 - 1003
  • [23] Comparing shear wave elastography and transient elastography in assessing liver fibrosis in patients with hepatitis B and hepatitis
    Halder, A.
    Fennessy, S.
    Faithful, T.
    Leung, J.
    Budge, T.
    Leembruggen, N.
    Saroj, N.
    Tuma, R.
    Sebastien, M.
    Kong, J.
    Hewavitharana, P.
    Mitchell, T.
    Kontorinis, N.
    Doyle, A.
    Cheng, W.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 : 66 - 66
  • [24] Comparison of the Enhanced Liver Fibrosis (ELF) score and transient elastography in haemophilia patients with chronic hepatitis C
    Boland, Greet
    van Manen, Lisa
    Mauser-Bunschoten, Evelien
    de Putte, Dietje Fransen-van
    van Erpecum, Karel J.
    HEPATOLOGY, 2013, 58 : 924A - 925A
  • [25] Enhanced Liver Fibrosis (ELF) test accurately identifies liver fibrosis in patients with chronic hepatitis C
    Parkes, J.
    Guha, I. N.
    Roderick, P.
    Harris, S.
    Cross, R.
    Manos, M. M.
    Irving, W.
    Zaitoun, A.
    Wheatley, M.
    Ryder, S.
    Rosenberg, W.
    JOURNAL OF VIRAL HEPATITIS, 2011, 18 (01) : 23 - 31
  • [26] Performance of Transient Elastography for the Staging of Liver Fibrosis in Patients with Chronic Hepatitis B: A Meta-Analysis
    Chon, Young Eun
    Choi, Eun Hee
    Song, Ki Jun
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Ahn, Sang Hoon
    Kim, Seung Up
    PLOS ONE, 2012, 7 (09):
  • [27] Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: a meta-analysis
    Kim, Seung Up
    Chon, Young Eun
    Park, Jun Yong
    Kim, Do Young
    Han, Kwang-Hyub
    Chon, Chae Yoon
    Ahn, Sang Hoon
    HEPATOLOGY, 2012, 56 : 841A - 841A
  • [28] The Easy Liver Fibrosis Test (eLIFT) for Predicting Advanced Liver Fibrosis in Patients with Chronic Hepatitis B
    Wang, Jian
    Chen, Zhong
    Yan, Xiaomin
    Yang, Yue
    Liu, Yong
    Chen, Yuxin
    Jia, Bei
    Xia, Juan
    Xiong, Yali
    Zhang, Zhaoping
    Ding, Weimao
    Huang, Rui
    Wu, Chao
    DISCOVERY MEDICINE, 2019, 28 (153) : 149 - 158
  • [29] Enhanced liver fibrosis score correlates with transient elastography in patients with treated autoimmune hepatitis
    Stoelinga, Anna
    de Vries, Elsemieke
    Tushuizen, Maarten
    Stattermayer, Albert
    Verhelst, Xavier
    Van Hoek, Bart
    JOURNAL OF HEPATOLOGY, 2022, 77 : S307 - S308
  • [30] Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool?
    Stasi, C.
    Arena, U.
    Vizzutti, F.
    Zignego, A. L.
    Monti, M.
    Laffi, G.
    Corti, G.
    Pinzani, M.
    DIGESTIVE AND LIVER DISEASE, 2009, 41 (12) : 863 - 866